We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
Cap. Flow
+$1B
Cap. Flow %
7.59%
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$120M
2
GL icon
Globe Life
GL
+$115M
3
MPT
Medical Properties Trust
MPT
+$91.5M
4
ACGL icon
Arch Capital
ACGL
+$69.2M
5
AMZN icon
Amazon
AMZN
+$45.6M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$138M
2
GSK icon
GSK
GSK
+$98.7M
3
CCK icon
Crown Holdings
CCK
+$92.3M
4
AWK icon
American Water Works
AWK
+$54M
5
SEDG icon
SolarEdge
SEDG
+$45.7M

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Financials 15.05%
3 Healthcare 13.07%
4 Consumer Discretionary 9.61%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EOD
2476
Allspring Global Dividend Opportunity Fund
EOD
$289M
$4K ﹤0.01%
841
-12,225
-94% -$55.9K
EUSA icon
2477
iShares MSCI USA Equal Weighted ETF
EUSA
$1.93B
$4K ﹤0.01%
+66
New +$4.44K
FORM icon
2478
FormFactor
FORM
$8.94B
$4K ﹤0.01%
106
+27
+34% +$975
FTDR icon
2479
Frontdoor
FTDR
$5.91B
$4K ﹤0.01%
80
+32
+67% +$1.46K
FTI icon
2480
TechnipFMC
FTI
$28.6B
$4K ﹤0.01%
626
– –
GALT icon
2481
Galectin Therapeutics
GALT
$318M
$4K ﹤0.01%
2,000
– –
CBIO
2482
Crescent Biopharma
CBIO
$635M
$4K ﹤0.01%
+12
New +$4.21K
HAE icon
2483
Haemonetics
HAE
$3.93B
$4K ﹤0.01%
+42
New +$4.52K
HRTX icon
2484
Heron Therapeutics
HRTX
$71M
$4K ﹤0.01%
200
– –
IBOC icon
2485
International Bancshares
IBOC
$4.5B
$4K ﹤0.01%
120
– –
ICHR icon
2486
Ichor Holdings
ICHR
$2.48B
$4K ﹤0.01%
138
-19
-12% -$537
KXI icon
2487
iShares Global Consumer Staples ETF
KXI
$1.06B
$4K ﹤0.01%
72
– –
LAD icon
2488
Lithia Motors
LAD
$8.25B
$4K ﹤0.01%
15
+8
+114% +$2.19K
MCRB icon
2489
Seres Therapeutics
MCRB
$48.4M
$4K ﹤0.01%
9
-1
-10% -$586
MKSI icon
2490
MKS Inc
MKSI
$20B
$4K ﹤0.01%
34
+21
+162% +$2.75K
MMT
2491
Aberdeen Multi-Market Income Fund
MMT
$241M
$4K ﹤0.01%
+720
New +$4.26K
MNRO icon
2492
Monro
MNRO
$369M
$4K ﹤0.01%
77
– –
MT icon
2493
ArcelorMittal
MT
$55.9B
$4K ﹤0.01%
237
-89
-27% -$1.56K
NAN icon
2494
Nuveen New York Quality Municipal Income Fund
NAN
$373M
$4K ﹤0.01%
310
– –
NMIH icon
2495
NMI Holdings
NMIH
$3.34B
$4K ﹤0.01%
193
+129
+202% +$2.94K
NUSC icon
2496
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
$4K ﹤0.01%
107
+28
+35% +$968
NVRI icon
2497
Enviri
NVRI
$628M
$4K ﹤0.01%
242
– –
OCCI
2498
OFS Credit Co
OCCI
$72.8M
$4K ﹤0.01%
+367
New +$3.57K
PATK icon
2499
Patrick Industries
PATK
$2.72B
$4K ﹤0.01%
96
+49
+104% +$2.08K
IFLN
2500
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
$4K ﹤0.01%
207
– –
98 99
100
101 102

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.

  • Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
  • Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
  • Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
  • Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
  • Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
  • Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
  • Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.